EDMONTON, ALBERTA -- (MARKET WIRE) -- 06/19/2006 -- ViRexx Medical Corp. (TSX: VIR) (AMEX: REX), a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that Marc Canton, President and Chief Operating Officer of ViRexx, presented at the Rodman & Renshaw Techvest Third Annual Security, BioDefense, & Connectivity Investor Conference in New York. A webcast of Mr. Canton's presentation is available at: http://www.wsw.com/webcast/rrshq9/rex. The event will be held from June 19th-20th, 2006 at the St. Regis Hotel, 2 E. 55th St. New York, NY.
